HFA Premium Access

Real-life evidence of the use of subcutaneous treprostinil in pulmonary hypertension in Argentina

Congress Session

About the speaker

Doctor Julieta Soricetti

Hospital Durand, Buenos Aires (Argentina)
0 follower

6 more presentations in this session

Serum proteome profiling reflects the risk of pulmonary hypertension in chronic heart failure patients

Speaker: Mr J. Morze (Olsztyn, PL)

Thumbnail

Hypertensive heart disease vs. Transthyretin cardiac amyloidosis: what are the differential features in real life?

Speaker: Doctor C. Goena Vives (Mendaro, ES)

Thumbnail

Association of right ventricular deformation parameters and pulmonary hypertension markers in patients with asymptomatic primary mitral regurgitation and preserved left ventricular ejection fraction

Speaker: Ms R. Dirsiene (Kaunas, LT)

Thumbnail

Artificial intelligence for prediction of pulmonary arterial hypertension detection using computer tomography

Speaker: Doctor T. Kivrak (Elazig, TR)

Thumbnail

Association between right ventricle size and function on outcomes in COVID-19

Speaker: Doctor N. Bodagh (London, GB)

Thumbnail

Access the full session

Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure and Hypertension

Speakers: Doctor J. Soricetti, Mr J. Morze, Doctor C. Goena Vives, Ms R. Dirsiene, Doctor T. Kivrak...
Thumbnail

About the event

Image

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Related content

ESC Premium Access

New foundational therapy in heart failure with reduced ejection fraction: should we keep following the 2016 European Society of Cardiology Heart Failure Guideline in 2021?

28 August 2021

Open Access

Evidence-based strategies to achieve low-risk status.

27 August 2021

Open Access

Long-term outcomes in PAH: Optimised approach to achieve the best outcomes.

27 August 2021

This platform is supported by

logo Novo Nordisk